Interactions between thrombophilic genetic mutations and clinical bleeding in patients on chronic oral anticoagulant treatment.

We studied the prevalence of genetic thrombophilic mutations in patients on chronic oral anticoagulant treatment (OAT) who had bleeding complications. In a case-control study we found ten (12.8%) carriers of factor V Leiden and two (2.